“Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy” (2024) Global Journal of Science Frontier Research, 24(G1), pp. 1–3. doi:10.34257/GJSFRGVOL24IS1PG1.